Cargando…
Small molecule inhibitors of HCV replication from Pomegranate
Hepatitis C virus (HCV) is the causative agent of end-stage liver disease. Recent advances in the last decade in anti HCV treatment strategies have dramatically increased the viral clearance rate. However, several limitations are still associated, which warrant a great need of novel, safe and select...
Autores principales: | Reddy, B. Uma, Mullick, Ranajoy, Kumar, Anuj, Sudha, Govindarajan, Srinivasan, Narayanaswamy, Das, Saumitra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067622/ https://www.ncbi.nlm.nih.gov/pubmed/24958333 http://dx.doi.org/10.1038/srep05411 |
Ejemplares similares
-
Structural and molecular basis of interaction of HCV non-structural protein 5A with human casein kinase 1α and PKR
por: Sudha, Govindarajan, et al.
Publicado: (2012) -
Potent HCV NS3 Protease Inhibition
by a Water-Soluble Phyllanthin Congener
por: B, Uma Reddy, et al.
Publicado: (2020) -
Multifaceted roles of plant derived small molecule inhibitors on replication cycle of SARS-CoV-2
por: Uma Reddy, B., et al.
Publicado: (2022) -
Identification of a flavonoid isolated from plum (Prunus domestica) as a potent inhibitor of Hepatitis C virus entry
por: Bose, Mihika, et al.
Publicado: (2017) -
The beta hairpin structure within ribosomal protein S5 mediates interplay between domains II and IV and regulates HCV IRES function
por: Bhat, Prasanna, et al.
Publicado: (2015)